The kidney as a target of hypertension

Current Hypertension Reports

Volumn 1, Issue 2, 1999, Pages 164-169

  Ljungman, Susanne ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTORS;

EID: 0033108034     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0014-9     Document Type: Article

References (39)

1. The United States Renal Data System: Excerpts from 1994 Annual Data report. Am J Kidney Dis 1994, 24(Suppl.2):S1-S166.
2. The United States Renal Data System: Excerpts from 1998 Annual Data report. Am J Kidney Dis 1998, 32(Suppl.1):S1-S142.
3. Blythe WB, Maddux FW: Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. Am J Kidney Dis 1991, 18:33-37.
4. Feldman HI, Klag MJ, Chiapella AP, et al.: End-stage renal disease in US minority groups. Am J Kidney Dis 1992, 19:397-410.
5. Perneger TV, Klag MJ, Whelton PK: Race and socioeconomic status in hypertension and renal disease. Curr Opin Nephrol Hypertens 1995, 4:235-239.
6. Rennie D: Renal rehabilitation: Where are the data? N Engl J Med 1981, 304:351-352.
7. Helmchen U, Wenzel UO: Benign and malignant nephrosclerosis and renovascular disease. In Renal Pathology: With Clinical and Functional Correlation. edn 3. Edited by Tischer C, Brenner BM. Philadelphia: JB Lippincott Co; 1994:1201-1236.
8. Sommers SC, Melamed J: Renal pathology of essential hypertension. Am J Hypertens 1990, 3:583-587.
9. Kashgarian M: Hypertensive disease and kidney structure. In Hypertension, Pathophysiology, Diagnosis and Management. Edited by Laragh JH, Brenner BM: New York: Raven Press; 1995:433-443.
10. Tracy RE: Blood pressure related separately to parenchymal fibrosis and vasculopathy of the kidney. Am J Kidney Dis 1992, 20:124-131.
11. Schlessinger SD, Tankersley MR, Curtis JJ: Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994, 23:655-660.
12. Harvey JM, Howie AJ, Lee SJ, et al.: Renal biopsy findings in hypertensive patients with proteinuria. Lancet 1992, 340:1435-1436.
13. Zucchelli P, Zuccalà A: Primary hypertension: How does it cause renal failure? Nephrol Dial Transplant 1994, 9:223-225.
14. Fogo A, Breyer JA, Smith MC, et al.: Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American study of kidney diseases (AASK) trial. Kidney Int 1997, 51:244-252. A biopsy study of African Americans with hypertension and impaired renal function showing a high prevalence of hypertensive nephrosclerosis.
15. Toto RD, Kirk KA, Coresh J, et al.: Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: Result from the African-American Study of Kidney Disease and Hypertension (AASK) pilot study. J Am Soc Nephrol 1997, 8:279-287.
16. Rosansky SJ, Hoover DR, King L, et al.: The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 1990, 150:2073-2076.
17. Bleyer AJ, Chen R, D'Agostino RB Jr, Appel RG: Clinical correlates of hypertensive end-stage renal disease. Am J Kidney Dis 1998, 31:28-34. An excellent review of the association between hypertensive ESRD and atherosclerosis.
18. Preston RA, Epstein M: Ischemic renal disease: An emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 1997, 15:1365-1377. An in-depth review of ischemic renal disease, a probably overlooked cause of end-stage renal disease.
19. Zucchelli P, Zuccalà A: Ischemic nephropathy in the elderly. Contrib Nephrol 1993, 105:13-24.
20. Gross CM, Krämer J, Waigand J, et al.: Relation between arteriosclerosis in the coronary and renal arteries. Am J Cardiol 1997, 80:1478-1481.
21. Walker WG, Neaton JD, Cutler JA, et al.: Renal function change in hypertensive members of the multiple Risk Factor Intervention Trial. JAMA 1992, 268:3085-3091.
22. Susic D, Frolich ED: Nephroprotective effect of antihypertensive drugs in essential hypertension J Hypertens 1998, 16:555-567.
23. Maki DD, Ma JZ, Louis TA, et al.: Long-term effects of the antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995, 155:1073-1080.
24. Himmelmann A, Hansson L, Hansson BG, et al.: Long-term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to b-blockade. Am J Hypertens 1996, 9:850-853.
25. Aurell M, Bengtsson C, Björck S: Enalapril versus metoprolol in primary hypertension: Effects on the glomerular filtration rate. Nephrol Dial Transplant 1997, 12:2289-2294. Treatment of patients with essetnial hypertension using an ACE inhibitor or a B-blocker for 6 years resulted in the same initial decline of GFR followed by the same stabilization of GFR in both treatment groups.
26. Siewert-Delle A, Ljungman S, Hartford M, et al.: Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension. Am J Hypertens 1996, 9:841-849.
27. Ljungman S, Wikstrand J, Hartford M, et al.: Effects of longterm antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension. Am J Hypertens 1993, 6:554-563.
28. Ruilope LM, Alcazar JM, Hernandez E, et al.: Does an adequate control of blood pressure protect the kidney in essential hypertension? J Hypertens 1990, 8:525-531.
29. Apperloo AJ, De Zeeuw D, De Jong PE: A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function. Kidney Int 1997, 51:793-797. A study of pateints having primary or secondary hypertension and reduced GFR showing that an initial fall in GFR in response to antihypertensive therapy was followed by stable renal function.
30. De Leeuw PW: Renal function in the elderly: Results from the European Working Party on High Blood Pressure in the Elderly Trial. Am J Med 1991, 90(suppl 3A):45S-49S.
31. Perneger TV, Nieto FJ, Whelton PK, et al.: A prospective study of blood pressure and serum creatinine. Results from the "Clue" study and the ARIC study. JAMA 1993, 269:488-493.
32. Schmieder RE, Veelken R, Gatzka CD, et al.: Predictors for hypertensive nephropathy: Results of a 6-year follow-up study in essential hypertension. J Hypertension 1994, 13:357-365.
33. Tomson CRV, Petersen K, Heagerty AM: Does treated essential hypertension result in renal impairment? A cohort study. J Hum Hypertens 1991, 5:189-192.
34. Madhavan S, Stockwell D, Cohen H, et al.: Renal function during antihypertensive treatment. Lancet 1995, 345:749-751.
35. Walker WG: Hypertension-related renal injury: A major contributor to end-stage renal disease Am J Kidney Dis 1993, 22:164-173.
36. Klag MJ, Whelton PK, Randall BL, et al.: Blood pressure and end-stage renal disease in men. N Engl J Med 1996, 334:13-18.
37. Iseki K, Ikemiya Y, Fukiyama K: Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int 1996, 49(suppl 55):S69-S71.
38. Perry HM Jr, Miller JP, Fornoff JR, et al.: Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995, 25(part 1):587-594.
39. Siewert-Delle A, Ljungman S, Andersson OK, et al.: Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Preventive Study in Göteborg, Sweden. Nephrol Dial Transplant 1998, 13:3084-3090. This new population-based prospective study indicates that middleaged white men do not develop progressive decline in renal function during 20 years if blood pressure is well controlled.